High distribution of 16S rRNA methylase genes rmtB and armA among Enterobacter cloacae strains isolated from an Ahvaz teaching hospital, Iran

Acta Microbiologica Et Immunologica Hungarica
Mansour AminTahereh Navidifar

Abstract

The emergence of 16S rRNA methylase genes encoded on plasmids confers high-level aminoglycoside resistance (HLAR). This study aimed to investigate the prevalence of 16S rRNA methylases among Enterobacter cloacae strains isolated from an Ahvaz teaching hospital, Iran. A total of 68 E. cloacae clinical strains were collected between November 2017 and September 2018. The MICs of aminoglycosides were assessed using the agar dilution method. The presence of 16S rRNA methylase genes, including armA, rmtA to rmtH, and nmpA was evaluated by PCR. The transferability of 16S rRNA methylase-harboring plasmids was evaluated by conjugation assay. The genetic diversity of all isolates was evaluated by ERIC-PCR. The armA and rmtB genes were the only 16S rRNA methylase genes detected in this study (29 out of 68 isolates; 42.64%). The transferability by conjugation was observed in 23 rmtB or/and armA positive donors. HLAR phenotype was in 33 of 68 strains. Ten clonal types were obtained by ERIC-PCR and significant associations (p < 0.05) were between the clone types and aminoglycoside susceptibility, as well as with profile of the 16S rRNA methylase genes. In conclusion, both horizontal transfer and clonal spread are responsible for disseminatio...Continue Reading

References

Apr 1, 1997·Clinical Microbiology Reviews·W E Sanders, C C Sanders
Jan 17, 2007·The Journal of Antimicrobial Chemotherapy·Pierre BogaertsYouri Glupczynski
Jun 8, 2007·Emerging Infectious Diseases·Kunikazu YamaneYoshichika Arakawa
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yohei Doi, Yoshichika Arakawa
Jul 9, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y ZhouM Wang
Jun 8, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jun-ichi Wachino, Yoshichika Arakawa
Mar 13, 2013·Antimicrobial Agents and Chemotherapy·Jessica A O'HaraYohei Doi
Jul 10, 2014·The Libyan Journal of Medicine·Yazeed A Al SheikhKhaled Homoud M Dabwab
Jun 5, 2015·Frontiers in Microbiology·Anne Davin-Regli, Jean-Marie Pagès
Oct 22, 2015·Emerging Infectious Diseases·Mohibur RahmanBruno Gonzalez-Zorn
Nov 6, 2015·Journal of Clinical Microbiology·Patrick McGannMary Hinkle
Feb 16, 2016·MedChemComm·Sylvie Garneau-Tsodikova, Kristin J Labby
Sep 16, 2016·Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University·Katarzyna PiekarskaRafał Gierczyński
Jan 1, 2014·The Libyan Journal of Medicine·Yazeed A Al SheikhKhaled Homoud M Dabwab
Mar 30, 2018·International Journal of Antimicrobial Agents·Emma TaylorKatie L Hopkins

❮ Previous
Next ❯

Citations

Jul 19, 2019·Clinical Microbiology Reviews·Anne Davin-RegliJean-Marie Pagès
Feb 27, 2020·Current Opinion in Pulmonary Medicine·Marlo Möller, Craig J Kinnear
Dec 14, 2019·Acta Microbiologica Et Immunologica Hungarica·Farkhondeh Saleh ShooshtariHamed Goodarzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.